EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Probiotics as Anti-Tumor Agents: Insights from Female Tumor Cell Culture Studies

Chiara Giorgi iD, Francesca Lombardi iD, Francesca Rosaria Augello, Ylli Alicka iD, Massimiliano Quintiliani, Skender Topi iD, Annamaria Cimini iD, Vanessa Castelli iD, Michele d'Angelo iD

Biomolecules · 2025

DOI: 10.3390/biom15050657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Chiara Giorgi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy. Hauptthemen laut MEDLINE: Probiotics, Antineoplastic Agents, Breast Neoplasms, Ovarian Neoplasms. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MIUR, the European Union-NextGenerationEU under the Italian University and Research (MUR) National Innovation Ecosystem, the Ministry of Enterprises and Made in Italy (MISE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast and ovarian cancers are among the most prevalent cancers in women. Cancerous cells are characterized by their ability to continuously cycle and migrate, forming metastases. Some probiotic strains have shown anti-tumorigenic effects. This study tested the impact of probiotics on OVCAR-3 and MDA-MB-231 cell lines by analyzing proteins involved in cell cycle regulation (pP53, Cyclin D1, pERK1), cell survival (AKT), and cell migration (RhoA) using Western blotting and scratch wound tests. Results indicated a reduction in these proteins and decreased cell migration velocity post-treatment. These findings suggest that certain probiotic combinations can arrest the cell cycle, promote cell death, and reduce cell migration, potentially serving as promising candidates alongside standard therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsAntineoplastic AgentsBreast NeoplasmsOvarian NeoplasmsHumansFemaleCell Line, TumorCell MovementCell SurvivalCell ProliferationCell Cycle

Stichwörter der Autor:innen

breast cancercancercell cyclemigrationovarian cancertriple negative

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
  • Department of Clinical Disciplines, University "Alexander Xhuvani" of Elbasan, 3001 Elbasan, Albania.
  • Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, Temple University, Philadelphia, PA 19122, USA.

ORCID-Profile: Chiara Giorgi, Francesca Lombardi, Ylli Alicka, Skender Topi, Annamaria Cimini, Vanessa Castelli, Michele d'Angelo

Förderung

  • MIUR
  • the European Union-NextGenerationEU under the Italian University and Research (MUR) National Innovation Ecosystem
  • the Ministry of Enterprises and Made in Italy (MISE)

Zitieren

APA

Giorgi, C., Lombardi, F., Augello, F. R., Alicka, Y., Quintiliani, M., Topi, S., Cimini, A., Castelli, V., & d'Angelo, M. (2025). Probiotics as Anti-Tumor Agents: Insights from Female Tumor Cell Culture Studies. Biomolecules. https://doi.org/10.3390/biom15050657

Vancouver

Giorgi C, Lombardi F, Augello FR, Alicka Y, Quintiliani M, Topi S, et al. Probiotics as Anti-Tumor Agents: Insights from Female Tumor Cell Culture Studies. Biomolecules. 2025. doi:10.3390/biom15050657

BibTeX
@article{Giorgi2025,
  author = {Giorgi, Chiara and Lombardi, Francesca and Augello, Francesca Rosaria and Alicka, Ylli and Quintiliani, Massimiliano and Topi, Skender and Cimini, Annamaria and Castelli, Vanessa and d'Angelo, Michele},
  title = {Probiotics as Anti-Tumor Agents: Insights from Female Tumor Cell Culture Studies},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15050657}
}
Kostenlos starten →